+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 6Months - 18Years
All Genders
ID06761560

Evaluating Pharmacokinetic Guided Hydroxyurea Dosage Versus Standard Care in Children and Adolescents With Moderate to Severe Sickle Cell Disease

Led by Yves Pastore · Updated on 2026-08-21

29

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with sickle cell disease to find out if monitoring hydroxyurea dosage using pharmacokinetic testing can help reach the maximum tolerated dose faster compared to standard bloodwork monitoring. The study includes children and adolescents aged 6 months to 18 years with specific sickle cell genotypes. Participants are divided into groups to compare different ways of adjusting hydroxyurea dosage over 12 months. Participants are randomized into three groups Group A will have their hydroxyurea dose adjusted based on pharmacokinetic results, Group B will have dose adjustments based on standard bloodwork follow-up, and Group C includes patients already on hydroxyurea for at least 12 months who will undergo a one-time pharmacokinetic test. The study follows participants for up to 12 months to evaluate dose adjustments and drug levels. During the study, participants will have pharmacokinetic blood samples collected at different times to monitor hydroxyurea levels and adjustments. Researchers will measure the time to reach the maximum tolerated dose, fetal hemoglobin levels, and safety through adverse event tracking. The primary outcome is the evaluation of hydroxyurea pharmacokinetics at 6 months between the groups, with further follow-up assessments up to 12 months.

CONDITIONS

Brief Title

Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia

Research Team

Y

Yves Pastore, MD

B

Bianka Courcelle, Research nurse, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here